DURABILITY OF APREMILAST RESPONSE IN PATIENTS WITH PSORIATIC ARTHRITIS: LONG-TERM (208-WEEK) RESULTS FROM THE PALACE 1 TRIAL

Conference contribution


Publication Details

Author(s): Kavanaugh A, Gladman DD, Gomez-Reino JJ, Hall S, Lespessailles E, Mease PJ, Schett G, Mcilraith M, Delev N, Paris M, Teng L, Wollenhaupt J
Publication year: 2017
Volume: 76
Pages range: 936-937
ISSN: 0003-4967


FAU Authors / FAU Editors

Schett, Georg Prof. Dr. med.
Lehrstuhl für Innere Medizin III


External institutions with authors

Celgene Corporation
Complejo Hospitalario Universitario de Santiago de Compostela
Monash University
Schön Klinik Hamburg Eilbek
Swedish Medical Center
University of California, San Diego
University of Orléans / Université d'Orléans
University of Toronto


How to cite

APA:
Kavanaugh, A., Gladman, D.D., Gomez-Reino, J.J., Hall, S., Lespessailles, E., Mease, P.J.,... Wollenhaupt, J. (2017). DURABILITY OF APREMILAST RESPONSE IN PATIENTS WITH PSORIATIC ARTHRITIS: LONG-TERM (208-WEEK) RESULTS FROM THE PALACE 1 TRIAL. (pp. 936-937).

MLA:
Kavanaugh, A., et al. "DURABILITY OF APREMILAST RESPONSE IN PATIENTS WITH PSORIATIC ARTHRITIS: LONG-TERM (208-WEEK) RESULTS FROM THE PALACE 1 TRIAL." 2017. 936-937.

BibTeX: 

Last updated on 2019-07-01 at 10:08